Skin Microbiome East 2019 | Kisaco Research

Free webinar: Euromonitor on the role of Skin Microbiome in the Evolution in Skin Care

View now
Revere Hotel Boston Common 200 Stuart St, Boston, MA 02116, USA
29-30 May, 2019

“Skin microbiome today is exploding with companies all over the world. Now we’re at a point where the awareness is so great that there’s almost like a tidal wave of interest in microbiome!”

Mike Conti, Solabia

Why Attend

“Skin microbiome today is exploding with companies all over the world. Now we’re at a point where the awareness is so great that there’s almost like a tidal wave of interest in microbiome!” - Mike Conti, Solabia

2018 saw the microbiome move to the forefront of over 300 industry leaders, who came together to exchange ideas at our Global Skin Microbiome Congress Series, the first dedicated congress focusing solely on Skin Microbiome.

With the microbiome set to be the biggest trend in skincare for 2019, we are incredibly excited to bring our flagship congress back to Boston, building on our success globally and connecting over 300 industry leaders.

This year, we take a deep-dive into the two key areas critical for success in this in this evolving field, with our 2 concurrent tracks of content. Track 1 will focus on developing a functional understanding of the microbiome, whereas track 2 will be focusing on builing a commercial viable business.

Don't miss the opportunity to join leading industry experts to explore next steps for skin microbiome research and development, as well as commercialization. 

The inaugural Skin Microbiome Congress in 2018 SOLD OUT, don't miss your chance to attend this year's event!

Submit a poster - deadline May 26th, 2019

Looking to showcase your recent work to the skin microbiome community?

Our dedicated poster area  is the perfect way to get your research noticed and further involve yourself in the congress. In order to present a poster at the forum you need to be registered as a delegate. Please note that there is limited space available and poster space is assigned on a first come first served basis (subject to checks and successful registration).

At the Congress, your presentation will be displayed in a dedicated poster area which can be viewed during the networking break.

CLICK HERE TO MAKE A SUBMISSION

Free Webinar Series

This year, we've taken a deep dive into some of the key challenges of Skin Microbiome and launched 2 exclusive webinars with our partners:

The Secret to Successful Formulation of
Skin Microbiome-based products 

HAPPI logo

As new data transpires to support the role of the skin microbiome in common conditions from acne and eczema to dandruff and skin allergies, Cosmetic Formulators are turning their attention to designing and testing products that contain live bacteria, bacterial extracts or prebiotic and postbiotic ingredients, to manipulate the skin's microbiota.
 
Tune in to:

  • Understand and explore how to successfully exploit Prebiotic, Probiotic and Postbiotic products as actives.
  • Explore the impact of preservatives, emulsifiers and other ingredients when formulating products.
  • Discover the opportunities and challenges when formulating preservative-free products.

CLICK HERE TO WATCH ON-DEMAND

=======================================

The role of Microbiome in the Evolution of Skincare

euromonitor_logo.png

This on-demand webinar provides an overview of the evolving skin care environment, further exploring the biggest trends and drivers for future growth.
Tune in to: 
  • Understand the consumer trends driving the skin care market
  • Learn what consumers look for in skin care and dermocosmetic products
  • Identify opportunities and challenges of the microbiome as the next big ingredient in beauty

CLICK HERE TO WATCH ON-DEMAND

HIGHLIGHTS FROM 2018

Skin Microbiome Congress Boston

Skin Microbiome Congress Testimonials

Who will be there

Meet Industry Leading Experts in:

  • Independent Beauty Brands and Biotech Companies;
  • Academic Researchers and Dermatologists;
  • Multinational Beauty & Personal Care Brands and Multinational Pharmaceutical Companies;
  • Cosmetic Formulators, Strain Manufacturers, Ingredients Suppliers, Packaging Manufacturers and Sequencing companies; 
  • Regulatory Experts and Consumer Trend Analysts; and
  • Retailers and Distributors

Skin Microbiome Past Attendees

Speakers

 

Anna Di Nardo

Professor of Dermatology
UCSD

Anna Di Nardo, MD, is a board-certified dermatologist who oversees the High Risk Pigmented Lesion Clinic. She also specializes in mole mapping and digital dermoscopy to detect early-stage melanoma.

As an associate professor in the Department of Dermatology at UC San Diego School of Medicine, Dr. Di Nardo leads her research lab, which focuses on mast cells and skin immunology. She has published over 100 scientific articles in top journals, including Nature MedicineJournal of Immunology and Journal of Investigative Dermatology.

Anna Di Nardo

Professor of Dermatology
UCSD

Anna Di Nardo

Professor of Dermatology
UCSD

Anna Di Nardo, MD, is a board-certified dermatologist who oversees the High Risk Pigmented Lesion Clinic. She also specializes in mole mapping and digital dermoscopy to detect early-stage melanoma.

As an associate professor in the Department of Dermatology at UC San Diego School of Medicine, Dr. Di Nardo leads her research lab, which focuses on mast cells and skin immunology. She has published over 100 scientific articles in top journals, including Nature MedicineJournal of Immunology and Journal of Investigative Dermatology.

From 1995-2001, Dr. Di Nardo was a clinical associate at University Hospital in Modena, Italy. From 2001-2005, she held the same position at San Gallicano Dermatological Institute (IRCCS) Rome.

Dr. Di Nardo completed fellowships at UC San Francisco School of Medicine and UC San Diego School of Medicine. She served her residency in dermatology at the University of Modena in Italy. She earned her medical degree from the University of Pavia, Italy, and her PhD in skin immunology and allergy at the University of Modena, Italy. Dr. Di Nardo is board-certified in dermatology.

She is a member of the Society for Investigative Dermatology, American Academy of Dermatology and the American Association of Immunologists.

Dr. Di Nardo is a recipient of the National Eczema Association Award and the Johnson & Johnson Focus on Giving Award for Outstanding Research.

She enjoys cooking, running, skiing, swimming and spending time with her family.

 

Bernhard Paetzold Ph.D

Co-Founder & Chief Scientific Officer
S-Biomedic

Bernhard completed his PhD in synthetic biology, working together in collaboration with the pharmaceutical industry to engineer bacteria as a living pill. He is a scientific co-founder of S-Biomedic, and is leading the research and product development. 

His passion is understanding the complex interplay of the bacterial communities that live within and on us. He is fascinated by the untouched potential of active compounds that are naturally produced everyday right on our own skin.

Bernhard Paetzold Ph.D

Co-Founder & Chief Scientific Officer
S-Biomedic

Bernhard Paetzold Ph.D

Co-Founder & Chief Scientific Officer
S-Biomedic

Bernhard completed his PhD in synthetic biology, working together in collaboration with the pharmaceutical industry to engineer bacteria as a living pill. He is a scientific co-founder of S-Biomedic, and is leading the research and product development. 

His passion is understanding the complex interplay of the bacterial communities that live within and on us. He is fascinated by the untouched potential of active compounds that are naturally produced everyday right on our own skin.

 

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

 

Elsa Jungman

Founder
ELSI Skin Health

Dr. Elsa Jungman has a Ph.D. in Skin Delivery and began her career working in Research and Development for L’Oreal in Paris. In 2015 she moved to San Francisco and has worked with several biotech and skincare companies such as AOBiome. She is an expert for the Clean Beauty Council at Credo Beauty and mentors/consults with local small companies. Today, she is the founder and CEO of ELSI Skin Health, a science-backed and clean skincare startup.

Elsa Jungman

Founder
ELSI Skin Health

Elsa Jungman

Founder
ELSI Skin Health

Dr. Elsa Jungman has a Ph.D. in Skin Delivery and began her career working in Research and Development for L’Oreal in Paris. In 2015 she moved to San Francisco and has worked with several biotech and skincare companies such as AOBiome. She is an expert for the Clean Beauty Council at Credo Beauty and mentors/consults with local small companies. Today, she is the founder and CEO of ELSI Skin Health, a science-backed and clean skincare startup.

 

Ingmar Claes, PhD

Chief Scientific Officer
YUN Probiotherapy

Ingmar studied bioscience engineering at the University of Leuven, graduated in 2007 and obtained a PhD in cell and gene technology in 2011. He has an expertise in the field of probiotics, its molecular mechanisms and the topical application of these beneficial bacteria to restore the human microbiome. As bioengineer and microbiologist, he feels that it is important to translate this scientific research into daily products from which people at home and the community can benefit.

Ingmar Claes, PhD

Chief Scientific Officer
YUN Probiotherapy

Ingmar Claes, PhD

Chief Scientific Officer
YUN Probiotherapy

Ingmar studied bioscience engineering at the University of Leuven, graduated in 2007 and obtained a PhD in cell and gene technology in 2011. He has an expertise in the field of probiotics, its molecular mechanisms and the topical application of these beneficial bacteria to restore the human microbiome. As bioengineer and microbiologist, he feels that it is important to translate this scientific research into daily products from which people at home and the community can benefit.

In the context of YUN, he is closely working together with the Department of Bioscience Engineering of the University of Antwerp, the Lab of Applied Microbiology and Biotechnology of prof. Sarah Lebeer, the Lab of Pharmaceutical Technology and Biopharmacy of prof. Filip Kiekens, prof. dr. Julien Lambert (dermatology) and dr. Gilbert Donders (gynaecology, the University Hospital of Antwerp).

He has experience with leadership in multiple R&D projects and he held a managing role in YUN’s R&D projects of the Flemish Institute for the Promotion of Scientific and Technological Research in Industry (VLAIO). YUN’s current range of probiotic products and therapies were developed under his supervision.

 

 

Kimberly Capone

Research Fellow Lead Microbiologist for Skin Microbiome Research
Johnson & Johnson Consumer Companies

Kimberly Capone is a Research Fellow and Lead Microbiologist for Skin Microbiome Research with Johnson & Johnson Consumer Companies, Inc. in Skillman, NJ. She received her B.S. in Biology from Northeastern University in Boston, MA, proceeding to earn her Ph.D. in Microbiology and Immunology from Northwestern University in Chicago, IL. As a Research Fellow at Johnson & Johnson Consumer Companies, Inc., Dr. Capone directs investigations into the human skin microbiome in health and disease, particularly early in life and in individuals with sensitive or inflamed skin.

Kimberly Capone

Research Fellow Lead Microbiologist for Skin Microbiome Research
Johnson & Johnson Consumer Companies

Kimberly Capone

Research Fellow Lead Microbiologist for Skin Microbiome Research
Johnson & Johnson Consumer Companies

Kimberly Capone is a Research Fellow and Lead Microbiologist for Skin Microbiome Research with Johnson & Johnson Consumer Companies, Inc. in Skillman, NJ. She received her B.S. in Biology from Northeastern University in Boston, MA, proceeding to earn her Ph.D. in Microbiology and Immunology from Northwestern University in Chicago, IL. As a Research Fellow at Johnson & Johnson Consumer Companies, Inc., Dr. Capone directs investigations into the human skin microbiome in health and disease, particularly early in life and in individuals with sensitive or inflamed skin. In the course of her work, Dr. Capone has authored numerous peer-reviewed papers and has participated in national and international dermatology conferences. 

 

Tuval Ben-Yehezkel, PhD

CEO
Loop Genomics

A scientist-entrepreneur focused on applied genomics and synthetic biology. Authored key patents, publications and book chapters in synthetic biology and genomics. Founded and secured $15.3M in funding for two biotech start-up companies.

Tuval Ben-Yehezkel, PhD

CEO
Loop Genomics

Tuval Ben-Yehezkel, PhD

CEO
Loop Genomics

A scientist-entrepreneur focused on applied genomics and synthetic biology. Authored key patents, publications and book chapters in synthetic biology and genomics. Founded and secured $15.3M in funding for two biotech start-up companies.

 

Mark Wilson

Chief Executive Officer
MatriSys BioScience

Mark Wilson

Chief Executive Officer
MatriSys BioScience

Mark Wilson

Chief Executive Officer
MatriSys BioScience
 

Maya Ivanjesku

Chief Scientific Officer
LaFlore

Maya has over twenty years experience as a formulation scientist in the pharmaceutical, cosmeceutical and biotech industries. She has managed multiple projects, including OTC’s, cosmeceuticals, Rx topicals, topical medical devices and nutraceuticals.

Maya Ivanjesku

Chief Scientific Officer
LaFlore

Maya Ivanjesku

Chief Scientific Officer
LaFlore

Maya has over twenty years experience as a formulation scientist in the pharmaceutical, cosmeceutical and biotech industries. She has managed multiple projects, including OTC’s, cosmeceuticals, Rx topicals, topical medical devices and nutraceuticals.

In consumer products, Maya worked as a senior research scientist/project manager for Estee Lauder, where she led the development of new formulations and products within the innovation/blue sky group. In addition, she created products for LaMer, Bare Essentials, Urban Decay, Joe Malone, Arbonne, Origins, Clinique and the list goes on. In biotechnology, she worked for numerous companies guiding chemists on developing new formulas, managing a team of scientists to support the R&D process and organizing, writing and executing calibrations, validation and performance on all lab equipment. One of the strongest values

Maya brings her expertise and knowledge of product development to LaFlore — from concept to commercialization with emphasis on pharmaceutical quality standards.

 

Tara Zedayko

Senior Marketing Manager, External Innovation Strategic Marketing
Johnson & Johnson Innovation | JLABS

Tara Zedayko is Senior Marketing Manager, External Innovation Strategic Marketing at Johnson & Johnson Innovation | JLABS. She has 12 years of J&J experience, spanning R&D, US marketing, and external innovation. Most recently, led AVEENO and RoC US businesses.

Tara Zedayko

Senior Marketing Manager, External Innovation Strategic Marketing
Johnson & Johnson Innovation | JLABS

Tara Zedayko

Senior Marketing Manager, External Innovation Strategic Marketing
Johnson & Johnson Innovation | JLABS

Tara Zedayko is Senior Marketing Manager, External Innovation Strategic Marketing at Johnson & Johnson Innovation | JLABS. She has 12 years of J&J experience, spanning R&D, US marketing, and external innovation. Most recently, led AVEENO and RoC US businesses.

 

Travis Whitfill

Co-Founder and Chief Scientific Officer
Azitra

Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.

Travis Whitfill

Co-Founder and Chief Scientific Officer
Azitra

Travis Whitfill

Co-Founder and Chief Scientific Officer
Azitra

Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.

His research interests are in pediatric emergency medicine and health policy and to improve pediatric acute care across the United States. 

 

Dr Whitney Bowe

Dermatologist and Media Expert

Renowned New York-based dermatologist Dr. Whitney Bowe is committed to achieving and maintaining the health and radiance of her patients’ skin. One of the most in-demand dermatologists in the country, Dr. Bowe specializes in skin rejuvenation, laser dermatology, and the link between nutrition and skincare.

Dr Whitney Bowe

Dermatologist and Media Expert

Dr Whitney Bowe

Dermatologist and Media Expert

Renowned New York-based dermatologist Dr. Whitney Bowe is committed to achieving and maintaining the health and radiance of her patients’ skin. One of the most in-demand dermatologists in the country, Dr. Bowe specializes in skin rejuvenation, laser dermatology, and the link between nutrition and skincare. Her work has earned the attention of top media outlets, netting her invitations to lend her expertise on programs like Good Morning AmericaThe Rachael Ray ShowThe Doctors, and Dr. Oz, and publications like The Wall Street Journal, The New York Times, ALLURE and INSTYLE.

Dr. Bowe attended Yale University, where she graduated Summa Cum Laude with a Bachelor of Science in Molecular, Cellular, and Developmental Biology. Upon graduation, she was named a 21st Century Gamble Scholar and was awarded a full scholarship to study medicine at the University of Pennsylvania where she graduated top of her class. 

 

Anthony Sabatelli

Patent Counsel
Wiggin and Dana

Anthony Sabatelli

Patent Counsel
Wiggin and Dana

Anthony Sabatelli

Patent Counsel
Wiggin and Dana
 

Dr. Eric Huang

Adjunct Professor of Medicine, Department of Dermatology
UCSD

Dr. Eric Huang

Adjunct Professor of Medicine, Department of Dermatology
UCSD

Dr. Eric Huang

Adjunct Professor of Medicine, Department of Dermatology
UCSD
 

Harald van der Hoeven

Director Technical Marketing
CLR - Berlin

 Harald van der Hoeven started to work in personal care in 1999 where he specialized on R&D and formulating of skin care cosmetics.

In 2006 Harald joined CLR in Berlin and took over as Director R&D. Since May 2013 he is Technical Marketing Director at CLR, involved in both R&D and technical and scientific support of CLR's customers.

Harald van der Hoeven

Director Technical Marketing
CLR - Berlin

Harald van der Hoeven

Director Technical Marketing
CLR - Berlin

 Harald van der Hoeven started to work in personal care in 1999 where he specialized on R&D and formulating of skin care cosmetics.

In 2006 Harald joined CLR in Berlin and took over as Director R&D. Since May 2013 he is Technical Marketing Director at CLR, involved in both R&D and technical and scientific support of CLR's customers.

 

Kathleen Dunnigan

Senior Staff Attorney
National Advertising Division

Kathleen Dunnigan

Senior Staff Attorney
National Advertising Division

Kathleen Dunnigan

Senior Staff Attorney
National Advertising Division
 

Jessica O'Connell

Partner
Covington & Burling LLP

Jessica O’Connell provides strategic advice to a broad range of companies and trade associations in engaging with food and drug regulatory bodies and Congress. She assists clients in complying with U.S. regulatory requirements for the manufacture and sale of foods, dietary supplements, cosmetics, OTC drugs, and animal products, and the import and export of FDA-regulated products. She also regularly counsels clients regarding potential crises, such as recalls and unanticipated regulatory attention.

Jessica O'Connell

Partner
Covington & Burling LLP

Jessica O'Connell

Partner
Covington & Burling LLP

Jessica O’Connell provides strategic advice to a broad range of companies and trade associations in engaging with food and drug regulatory bodies and Congress. She assists clients in complying with U.S. regulatory requirements for the manufacture and sale of foods, dietary supplements, cosmetics, OTC drugs, and animal products, and the import and export of FDA-regulated products. She also regularly counsels clients regarding potential crises, such as recalls and unanticipated regulatory attention.

Ms. O’Connell is expert in issues relating the implementation of the FDA Food Safety Modernization Act (FSMA) and has advised clients both within the United States and abroad on compliance with the range of new requirements under that legislation. She also works closely with food, cosmetic, and OTC clients to develop labeling and advertising options that are low-risk from both a regulatory and litigation perspective while also meeting marketing goals and objectives, and has specific expertise regarding organic labeling, “healthy” claims, and claim substantiation requirements. Ms. O’Connell has engaged with Congress on cosmetic legislative efforts and food labeling requirements, and has prepared comments on behalf of individual companies and trade associations to FDA, USDA, and the NOSB.

 

Larry Weis

CEO & Founder
Persona Biome

Larry Weiss is the CEO and Founder of Persona Biome, a San Francisco skin microbiome company.  Previously, he was founding Chief Medical Officer at AOBiome where he formulated AOB-101, the first live topical biotherapeutic and ran the first successful virtual clinical trial.   He also developed the Mother Dirt cosmetics including AO Mist, the first live skin probiotic. He has an extensive background in natural products chemistry, microbiology, medicine, biophysics, and pharmaceutical and cosmetic product development.

Larry Weis

CEO & Founder
Persona Biome

Larry Weis

CEO & Founder
Persona Biome

Larry Weiss is the CEO and Founder of Persona Biome, a San Francisco skin microbiome company.  Previously, he was founding Chief Medical Officer at AOBiome where he formulated AOB-101, the first live topical biotherapeutic and ran the first successful virtual clinical trial.   He also developed the Mother Dirt cosmetics including AO Mist, the first live skin probiotic. He has an extensive background in natural products chemistry, microbiology, medicine, biophysics, and pharmaceutical and cosmetic product development. He  has an MD from Stanford University, and a BS in Biochemistry from Cornell University. He has over 20 patents and is published in the areas of chemistry, electrophysiology, clinical pharmacology, and the microbiome.

 

 

Tami Lieberman

Assistant Professor
Massachusetts Institute of Technology (MIT)

Tami Lieberman joined the MIT faculty in January 2018. She leads a computational and experimental research group focused on uncovering the principles governing colonization, niche range, and personalization in the human microbiome.

Tami Lieberman

Assistant Professor
Massachusetts Institute of Technology (MIT)

Tami Lieberman

Assistant Professor
Massachusetts Institute of Technology (MIT)

Tami Lieberman joined the MIT faculty in January 2018. She leads a computational and experimental research group focused on uncovering the principles governing colonization, niche range, and personalization in the human microbiome.

Tami trained in molecular biology and mathematics at Northwestern University, where she conducted research in the laboratory of Jon Widom and was funded by a Barry M. Goldwater Scholarship. She then earned a PhD in Systems Biology from Harvard University, where she conducted research in Roy Kishony’s laboratory. During her graduate research, Tami developed new genomic approaches for understanding how bacteria evolve during infections of individual people. As a postdoc in Eric Alm’s lab at MIT, she further developed and applied these genomic approaches to understand the microbes that colonize us during health. Tami has also made contributions to our understanding of antibiotic resistance, including the co-invention of a new platform for visualizing evolution in real time. Her work has been covered in the popular press, including online coverage from The Atlantic, The Wall Street Journal, National Geographic, The Boston Globe, and ArsTechnia.

 

Valerie Casagrande

Founder
BIOMILK Probiotic Skincare

Valerie Casagrande is the founder of BIOMILK Probiotic Skincare, the first natural beauty brand supporting the health of your skin through complete healthy nutrition. Valerie graduated from ESCEM School of Business and Management in France. Moving soon after to the US and prior to launching BIOMILK, she spent 12 years leading the growth of well-known international brands in the beauty, personal care and health space at Johnson & Johnson and Church & Dwight.

Valerie Casagrande

Founder
BIOMILK Probiotic Skincare

Valerie Casagrande

Founder
BIOMILK Probiotic Skincare

Valerie Casagrande is the founder of BIOMILK Probiotic Skincare, the first natural beauty brand supporting the health of your skin through complete healthy nutrition. Valerie graduated from ESCEM School of Business and Management in France. Moving soon after to the US and prior to launching BIOMILK, she spent 12 years leading the growth of well-known international brands in the beauty, personal care and health space at Johnson & Johnson and Church & Dwight. In its first year in market, BIOMILK was awarded most innovative natural brand at Cosmoprof NA 2018, and is now growing in the US and Internationally.

 

Alexander Gordon James

Science Leader
Unilever

Gordon originates from Glasgow in Scotland, and was educated at University of Glasgow, graduating with a BSc and PhD in Biochemistry in 1987 and 1991, respectively.  He then did a postdoctoral fellowship at University of Strathclyde in the area of environmental biotechnology, during which time he began practicing his favoured discipline of microbial biochemistry.  Gordon joined Unilever R&D in 1993, and in the time since, his main focus has been using his microbial biochemistry skills to unravel the origins of axillary (underarm) odour.  His current role is to provide scientific leaders

Alexander Gordon James

Science Leader
Unilever

Alexander Gordon James

Science Leader
Unilever

Gordon originates from Glasgow in Scotland, and was educated at University of Glasgow, graduating with a BSc and PhD in Biochemistry in 1987 and 1991, respectively.  He then did a postdoctoral fellowship at University of Strathclyde in the area of environmental biotechnology, during which time he began practicing his favoured discipline of microbial biochemistry.  Gordon joined Unilever R&D in 1993, and in the time since, his main focus has been using his microbial biochemistry skills to unravel the origins of axillary (underarm) odour.  His current role is to provide scientific leadership to a UK-based team specialising in this topic on behalf of Unilever’s Deodorants category and the global Science & Technology Platform, Human Microbiome

 

Nichola Eliovits

Chief Business Officer & Co-Founder
Dermbiont

Nick's investment expertise spans across asset classes with an extensive focus on microbiome oriented companies across all stages of venture capital.

Nick is a Managing Partner at Olive Tree Capital; he led his last company through acquisition and has successfully seeded and structured companies across multiple industries.

His passion for the Microbiome originates from personal experiences with fungal skin infections and c-diff.

Nichola Eliovits

Chief Business Officer & Co-Founder
Dermbiont

Nichola Eliovits

Chief Business Officer & Co-Founder
Dermbiont

Nick's investment expertise spans across asset classes with an extensive focus on microbiome oriented companies across all stages of venture capital.

Nick is a Managing Partner at Olive Tree Capital; he led his last company through acquisition and has successfully seeded and structured companies across multiple industries.

His passion for the Microbiome originates from personal experiences with fungal skin infections and c-diff.

Nick graduated with honors from Boston University’s Questrom School of Business and started his career in commodity markets at CPM Group in New York.

 

Teruaki Nakatsuji

Associate Project Scientist
USCD

Teruaki Nakatsuji

Associate Project Scientist
USCD

Teruaki Nakatsuji

Associate Project Scientist
USCD
 

Tom Verlinden

CEO
Yun Probiotherapy

Tom Verlinden obtained a Master in Pharmaceutical Science (University of Antwerp) and a master  in Industrial Pharmacy (IPIL, France). Tom substantiated his knowledge at the EM Lyon business school and proceeded to work in a mid-sized pharmaceutical company (Production Manager at Gifrer et SEV, France). Tom has experience with leading/managerial positions, since he has many years of experience in management positions (Vice-président and COO) at Qualiphar (Belgium) and (Vice-président and Responsible Pharmacist) at Gifrer SAS (France).

Tom Verlinden

CEO
Yun Probiotherapy

Tom Verlinden

CEO
Yun Probiotherapy

Tom Verlinden obtained a Master in Pharmaceutical Science (University of Antwerp) and a master  in Industrial Pharmacy (IPIL, France). Tom substantiated his knowledge at the EM Lyon business school and proceeded to work in a mid-sized pharmaceutical company (Production Manager at Gifrer et SEV, France). Tom has experience with leading/managerial positions, since he has many years of experience in management positions (Vice-président and COO) at Qualiphar (Belgium) and (Vice-président and Responsible Pharmacist) at Gifrer SAS (France).

 

Dr. Julie Horvath

Head of the Genomics & Microbiology Research Lab at the North Carolina Museum of Natural Sciences AND jointly appointed Research Associate Professor at North Carolina Central University
North Carolina Central University

Dr. Julie Horvath is a comparative evolutionary genomicist interested in understanding the evolutionary forces that have shaped primate genomes and that cause human disease. Genetic and genomic comparisons between humans and our closest relatives, the primates, are crucial for understanding our own evolution and unique characteristics. The foundation of Dr. Horvath’s research is based on species relationships, or phylogenies, which she first established for lemurs, and more recently, for all primates. These species relationships are applied to many of her research questions.

Dr. Julie Horvath

Head of the Genomics & Microbiology Research Lab at the North Carolina Museum of Natural Sciences AND jointly appointed Research Associate Professor at North Carolina Central University
North Carolina Central University

Dr. Julie Horvath

Head of the Genomics & Microbiology Research Lab at the North Carolina Museum of Natural Sciences AND jointly appointed Research Associate Professor at North Carolina Central University
North Carolina Central University

Dr. Julie Horvath is a comparative evolutionary genomicist interested in understanding the evolutionary forces that have shaped primate genomes and that cause human disease. Genetic and genomic comparisons between humans and our closest relatives, the primates, are crucial for understanding our own evolution and unique characteristics. The foundation of Dr. Horvath’s research is based on species relationships, or phylogenies, which she first established for lemurs, and more recently, for all primates. These species relationships are applied to many of her research questions. Several examples of Horvath’s research investigate the connection between genotype (DNA sequence) and phenotype (traits and characteristics) that make flora and fauna unique. 

 

Jennifer Cookson

Director of Research and Product Development
Mother Dirt

Jennifer Cookson is the Director of Research and Product Development at Mother Dirt, a personal care company with a line of biome-friendly products focused on restoring and maintaining the delicate balance of the skin biome. She has spent most of her career in the personal care and cosmetic space as a formulator and holds degrees in Chemistry and Environmental Science from the University of Vermont.

Jennifer Cookson

Director of Research and Product Development
Mother Dirt

Jennifer Cookson

Director of Research and Product Development
Mother Dirt

Jennifer Cookson is the Director of Research and Product Development at Mother Dirt, a personal care company with a line of biome-friendly products focused on restoring and maintaining the delicate balance of the skin biome. She has spent most of her career in the personal care and cosmetic space as a formulator and holds degrees in Chemistry and Environmental Science from the University of Vermont. She has combined her interests and experience in biochemistry, polymer and green chemistry to help advance research in formulations containing live microorganisms and the definition of biome-friendly formulations and products.

 

Dr. Otgonchimeg (Oti) Rentsendorj

Staff Fellow
Cosmetics Division, Office of Cosmetics and Colors at United States Food and Drug Administration

Dr. Otgonchimeg Rentsendorj is a Staff Fellow, Biologist-Microbiologist. She specializes in cosmetic ingredients safety reviews, contributes in regularly, compliance, and communications fields. She also provides expertise and guidance in in vitro/in vivo research/review projects. Oti received her Master’s in Microbiology from Kazan Federal University, Russia, and her Ph.D. in Molecular Biology from Hungarian Academy of Sciences, Hungary. She has 4 years of FDA research/regulatory experience and 10 years of academic experience at JHU School of Medicine.

Dr. Otgonchimeg (Oti) Rentsendorj

Staff Fellow
Cosmetics Division, Office of Cosmetics and Colors at United States Food and Drug Administration

Dr. Otgonchimeg (Oti) Rentsendorj

Staff Fellow
Cosmetics Division, Office of Cosmetics and Colors at United States Food and Drug Administration

Dr. Otgonchimeg Rentsendorj is a Staff Fellow, Biologist-Microbiologist. She specializes in cosmetic ingredients safety reviews, contributes in regularly, compliance, and communications fields. She also provides expertise and guidance in in vitro/in vivo research/review projects. Oti received her Master’s in Microbiology from Kazan Federal University, Russia, and her Ph.D. in Molecular Biology from Hungarian Academy of Sciences, Hungary. She has 4 years of FDA research/regulatory experience and 10 years of academic experience at JHU School of Medicine. Her background is in microbiology, cellular/molecular biology, and bioinformatics, has ˃50 peer-reviewed papers and abstracts.

 

William Lee

CEO & Co-Founder
EpigenCare

William Lee is an entrepreneur with over 10 years of experience in both the biotechnology and entertainment sectors. He is currently a shareholder and senior executive of EpiGentek Group Inc., a biotechnology reagents company specializing in epigenetics, and had also previously founded music licensing and gaming ventures. He has significant experience in management, operations, web development, and both B2B and B2C marketing. Having a passion for disruptive technologies, he invested in Bitcoin in 2013 and subsequently Ethereum in its early days.

William Lee

CEO & Co-Founder
EpigenCare

William Lee

CEO & Co-Founder
EpigenCare

William Lee is an entrepreneur with over 10 years of experience in both the biotechnology and entertainment sectors. He is currently a shareholder and senior executive of EpiGentek Group Inc., a biotechnology reagents company specializing in epigenetics, and had also previously founded music licensing and gaming ventures. He has significant experience in management, operations, web development, and both B2B and B2C marketing. Having a passion for disruptive technologies, he invested in Bitcoin in 2013 and subsequently Ethereum in its early days. William Lee studied at New York University and Carnegie Mellon University. While pursuing his MBA at the Carnegie Mellon Tepper School of Business, William realized the vast startup opportunity in the blockchain space and sought to bring the disruptive technology into consumer biotech.

 

Giorgio Dell’Acqua

Scientific Director
Nutrafol

Giorgio Dell’Acqua, PhD, is a cosmetic scientist and a consultant for the personal care industry. A graduated from the University of Rome, Italy, he worked for 15 years as an investigator in applied medical research in Universities such as Mount Sinai Medical School in New York and Harvard Medical School in Boston. Moving to the private sector in 2000, he has spent the last 19 years as an executive and cosmetic scientist in the personal care industry. He is specialized in skin and hair care ingredients, finished product development and technical marketing.

Giorgio Dell’Acqua

Scientific Director
Nutrafol

Giorgio Dell’Acqua

Scientific Director
Nutrafol

Giorgio Dell’Acqua, PhD, is a cosmetic scientist and a consultant for the personal care industry. A graduated from the University of Rome, Italy, he worked for 15 years as an investigator in applied medical research in Universities such as Mount Sinai Medical School in New York and Harvard Medical School in Boston. Moving to the private sector in 2000, he has spent the last 19 years as an executive and cosmetic scientist in the personal care industry. He is specialized in skin and hair care ingredients, finished product development and technical marketing. He has helped bring more than 200 successful active ingredients and finished products to market and has authored more than 60 publications in medicine and cosmetic science. From last 10 years he has been writing and lecturing on natural cosmetic ingredients, sustainable supply chain, and helped sourcing, developing and bringing to market many natural ingredients. Some of his recent product development activity has focused on food by products to cosmetics, prebiotics to skin, and adaptogens for skin and hair care. He is an award winning speaker on natural ingredients and a regular columnist on sustainability and cosmetic science. He is also the chair of the Scientific Committee for the New York Society of Cosmetic Chemists and its scientific blogger.

 

Dr. Nur A Hasan

CSO
CosmosID

Dr. Nur A Hasan is a molecular microbiologist with experiences in microbial genomics, metagenomics, and molecular ecology. Dr. Hasan is the Chief Scientific Officer at CosmosID Inc. and an adjunct faculty at the Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD. Dr. Hasan received his Bachelor and Masters in Microbiology, M.B.A in Marketing and Ph.D. in Molecular Biology. He has authored over 75 peer-reviewed articles and over 70 conference proceedings. Currently, Dr.

Dr. Nur A Hasan

CSO
CosmosID

Dr. Nur A Hasan

CSO
CosmosID

Dr. Nur A Hasan is a molecular microbiologist with experiences in microbial genomics, metagenomics, and molecular ecology. Dr. Hasan is the Chief Scientific Officer at CosmosID Inc. and an adjunct faculty at the Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD. Dr. Hasan received his Bachelor and Masters in Microbiology, M.B.A in Marketing and Ph.D. in Molecular Biology. He has authored over 75 peer-reviewed articles and over 70 conference proceedings. Currently, Dr. Hasan is leading an effort in developing the world’s largest curated genome databases and ultra rapid bioinformatics platform for pathogen detection and cross-disciplinary microbiome research.

Agenda

Simply fill in this form we'll send you a PDF version immediately. We need some information to know where to send the file and how to address our email to you.

Take a look at our highlights video from the inaugural congress: 

Skin Microbiome Congress | 30 - 31 May 2018

3rd Annual European Microbiome Congress: The Next Big Thing in Microbiome...Skin

Download Agenda

Thought Leadership Partner

Senior Event Partner

Event Partners

Media Partners

Become a Sponsor

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

Venue

Revere Hotel Boston Common 200 Stuart St, Boston, MA 02116, USA

The Skin Microbiome Congress will be taking place in Revere Hotel Boston Common 200 Stuart St, Boston, MA 02116, USA.

Shaped by the local culture and rebellious, independent spirit fueling Boston since its founding, Revere Hotel Boston Common is the downtown hotel for the adventurous and authentic. Find our hotel steps from Boston's Theater District, Newbury Street, and Copley Square. Stay in boutique rooms with balconies overlooking the city skyline and our Back Bay neighborhood. 

Unfortunately all rooms are now sold out at the Revere Hotel Boston Common. If you need accommodation to atten the event, please book at the Boston Park Plaza.

Alternative accomodation:

Boston Park Plaza  (0.2 mile from Revere Hotel), 50 Park Plaza at Arlington, Boston, MA, 02116

Superior Queen Bed -  $309.00 + 14.45% tax per night,  quote reference: KISACO - Book by April 30th, after this date rates are subject to availability.

Call to make a reservation: + 1 617-379-7129

Click here to book online 

Skin Microbiome Boston Venue

Accessibility:

We are committed to making our event accessible for everyone. If you are traveling for the event, Cloud of Goods provides mobility scooter rentals, wheelchair rentals, and other mobility solutions. They will deliver directly to you at the event, your hotel, the airport, or any other place of your choosing. Event attendees will receive a 20% discount when they use the code: RENTGEAR032

Visit: https://www.cloudofgoods.com/ 

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Preparing registration...

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Other events you might be interested in:

Skin Microbiome Westcoast 2019

Skin Microbiome EU 2019

Skin Microbiome Asia 2019